Alembic Pharmaceuticals Ltd
NSE:APLLTD

Watchlist Manager
Alembic Pharmaceuticals Ltd Logo
Alembic Pharmaceuticals Ltd
NSE:APLLTD
Watchlist
Price: 1 035.45 INR -0.93% Market Closed
Market Cap: 203.5B INR
Have any thoughts about
Alembic Pharmaceuticals Ltd?
Write Note

Intrinsic Value

The intrinsic value of one APLLTD stock under the Base Case scenario is 963.73 INR. Compared to the current market price of 1 035.45 INR, Alembic Pharmaceuticals Ltd is Overvalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

APLLTD Intrinsic Value
963.73 INR
Overvaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Alembic Pharmaceuticals Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
APLLTD
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for APLLTD cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about APLLTD?
Bearish
Neutral
Bullish

Fundamental Analysis

1 035.45 INR
-0.93%
-0.93%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Alembic Pharmaceuticals Ltd
IN
Pharmaceuticals
Market Cap
203.5B INR
IPO
Sep 17, 2011
Employees
12 160
India
Market Cap
203.5B INR
Industry
Pharmaceuticals
IPO
Sep 17, 2011
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Alembic Pharmaceuticals Ltd

Provide an overview of the primary business activities
of Alembic Pharmaceuticals Ltd.

What unique competitive advantages
does Alembic Pharmaceuticals Ltd hold over its rivals?

What risks and challenges
does Alembic Pharmaceuticals Ltd face in the near future?

Has there been any significant insider trading activity
in Alembic Pharmaceuticals Ltd recently?

Summarize the latest earnings call
of Alembic Pharmaceuticals Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Alembic Pharmaceuticals Ltd.

Provide P/S
for Alembic Pharmaceuticals Ltd.

Provide P/E
for Alembic Pharmaceuticals Ltd.

Provide P/OCF
for Alembic Pharmaceuticals Ltd.

Provide P/FCFE
for Alembic Pharmaceuticals Ltd.

Provide P/B
for Alembic Pharmaceuticals Ltd.

Provide EV/S
for Alembic Pharmaceuticals Ltd.

Provide EV/GP
for Alembic Pharmaceuticals Ltd.

Provide EV/EBITDA
for Alembic Pharmaceuticals Ltd.

Provide EV/EBIT
for Alembic Pharmaceuticals Ltd.

Provide EV/OCF
for Alembic Pharmaceuticals Ltd.

Provide EV/FCFF
for Alembic Pharmaceuticals Ltd.

Provide EV/IC
for Alembic Pharmaceuticals Ltd.

Show me price targets
for Alembic Pharmaceuticals Ltd made by professional analysts.

What are the Revenue projections
for Alembic Pharmaceuticals Ltd?

How accurate were the past Revenue estimates
for Alembic Pharmaceuticals Ltd?

What are the Net Income projections
for Alembic Pharmaceuticals Ltd?

How accurate were the past Net Income estimates
for Alembic Pharmaceuticals Ltd?

What are the EPS projections
for Alembic Pharmaceuticals Ltd?

How accurate were the past EPS estimates
for Alembic Pharmaceuticals Ltd?

What are the EBIT projections
for Alembic Pharmaceuticals Ltd?

How accurate were the past EBIT estimates
for Alembic Pharmaceuticals Ltd?

Compare the revenue forecasts
for Alembic Pharmaceuticals Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Alembic Pharmaceuticals Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Alembic Pharmaceuticals Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Alembic Pharmaceuticals Ltd compared to its peers.

Compare the P/E ratios
of Alembic Pharmaceuticals Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Alembic Pharmaceuticals Ltd with its peers.

Analyze the financial leverage
of Alembic Pharmaceuticals Ltd compared to its main competitors.

Show all profitability ratios
for Alembic Pharmaceuticals Ltd.

Provide ROE
for Alembic Pharmaceuticals Ltd.

Provide ROA
for Alembic Pharmaceuticals Ltd.

Provide ROIC
for Alembic Pharmaceuticals Ltd.

Provide ROCE
for Alembic Pharmaceuticals Ltd.

Provide Gross Margin
for Alembic Pharmaceuticals Ltd.

Provide Operating Margin
for Alembic Pharmaceuticals Ltd.

Provide Net Margin
for Alembic Pharmaceuticals Ltd.

Provide FCF Margin
for Alembic Pharmaceuticals Ltd.

Show all solvency ratios
for Alembic Pharmaceuticals Ltd.

Provide D/E Ratio
for Alembic Pharmaceuticals Ltd.

Provide D/A Ratio
for Alembic Pharmaceuticals Ltd.

Provide Interest Coverage Ratio
for Alembic Pharmaceuticals Ltd.

Provide Altman Z-Score Ratio
for Alembic Pharmaceuticals Ltd.

Provide Quick Ratio
for Alembic Pharmaceuticals Ltd.

Provide Current Ratio
for Alembic Pharmaceuticals Ltd.

Provide Cash Ratio
for Alembic Pharmaceuticals Ltd.

What is the historical Revenue growth
over the last 5 years for Alembic Pharmaceuticals Ltd?

What is the historical Net Income growth
over the last 5 years for Alembic Pharmaceuticals Ltd?

What is the current Free Cash Flow
of Alembic Pharmaceuticals Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Alembic Pharmaceuticals Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Alembic Pharmaceuticals Ltd

Current Assets 37.6B
Cash & Short-Term Investments 1.4B
Receivables 13B
Other Current Assets 23.2B
Non-Current Assets 34.7B
Long-Term Investments 1B
PP&E 31.2B
Other Non-Current Assets 2.4B
Current Liabilities 21.7B
Accounts Payable 8.9B
Short-Term Debt 9.9B
Other Current Liabilities 2.9B
Non-Current Liabilities 1.7B
Long-Term Debt 534.3m
Other Non-Current Liabilities 1.2B
Efficiency

Earnings Waterfall
Alembic Pharmaceuticals Ltd

Revenue
63.6B INR
Cost of Revenue
-16.6B INR
Gross Profit
46.9B INR
Operating Expenses
-39.7B INR
Operating Income
7.2B INR
Other Expenses
-772.6m INR
Net Income
6.5B INR

Free Cash Flow Analysis
Alembic Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

APLLTD Profitability Score
Profitability Due Diligence

Alembic Pharmaceuticals Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive Free Cash Flow
Positive 3-Years Revenue Growth
55/100
Profitability
Score

Alembic Pharmaceuticals Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

APLLTD Solvency Score
Solvency Due Diligence

Alembic Pharmaceuticals Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
High Interest Coverage
69/100
Solvency
Score

Alembic Pharmaceuticals Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

APLLTD Price Targets Summary
Alembic Pharmaceuticals Ltd

Wall Street analysts forecast APLLTD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APLLTD is 1 195.54 INR with a low forecast of 903.95 INR and a high forecast of 1 482.6 INR.

Lowest
Price Target
903.95 INR
13% Downside
Average
Price Target
1 195.54 INR
15% Upside
Highest
Price Target
1 482.6 INR
43% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for APLLTD?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for APLLTD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

APLLTD Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one APLLTD stock?

The intrinsic value of one APLLTD stock under the Base Case scenario is 963.73 INR.

Is APLLTD stock undervalued or overvalued?

Compared to the current market price of 1 035.45 INR, Alembic Pharmaceuticals Ltd is Overvalued by 7%.

Back to Top